Not logged inTreatment of High-Risk Biochemically Recurrent Prostate Cancer With Enzalutamide in Combination With Leuprolide: Secondary End Points From the EMBARK Trial
Shore, Neal D.; Gleave, Martin; De Giorgi, Ugo; Rannikko, Antti; Pieczonka, Christopher M.; Sridharan, Swetha; Brasso, Klaus; Woo, Henry H.; Gomez Caamano, Antonio; Saranchuk, Jeff W.; Nordquist, Luke T.; Ferreira, Ubirajara; Tang, Yiyun; Rosbrook, Brad; Haas, Gabriel P.; Rosales, Matt; Zohren, Fabian; Tarazi, Jamal; Freedland, Stephen J. .png)
Share.png)
SaveThe Comparative Outcomes of Radical Prostatectomy versus Radiotherapy for Nonmetastatic Prostate Cancer: A Longitudinal, Population-Based AnalysisOake, Justin D.; Shiff, Benjamin; Harasemiw, Oksana; Tangri, Navdeep; Ferguson, Thomas W.; Bhindi, Bimal; Saranchuk, Jeff W.; Bansal, Rahul K.; Drachenberg, Darrel E.; Nayak, Jasmir G. Share Save Share Save Share Save 3D nuclear telomeric signatures define circulating tumor cells (CTCs) and characterize CTC subpopulations in intermediate risk prostate cancer patientsJulius, Awe A.; Yan, Adam; Shah, Nidhi; Ludger, Klewes; Kuzyk, Alexandra; Xu, Michael; Boles, Ramy; Saranchuk, Jeff; Drachenberg, Darrel; Mai, Sabine Share Save Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
